[
  {
    "ts": null,
    "headline": "SDZNY vs. ZTS: Which Stock Should Value Investors Buy Now?",
    "summary": "SDZNY vs. ZTS: Which Stock Is the Better Value Option?",
    "url": "https://finnhub.io/api/news?id=aef09ae3a19c38c424304e37a752f76534a6fa6da3b6a3ac085f2dbc782d8f83",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731948016,
      "headline": "SDZNY vs. ZTS: Which Stock Should Value Investors Buy Now?",
      "id": 131461324,
      "image": "https://media.zenfs.com/en/zacks.com/4f1a8d86cead9f96536efb147945dcc9",
      "related": "ZTS",
      "source": "Yahoo",
      "summary": "SDZNY vs. ZTS: Which Stock Is the Better Value Option?",
      "url": "https://finnhub.io/api/news?id=aef09ae3a19c38c424304e37a752f76534a6fa6da3b6a3ac085f2dbc782d8f83"
    }
  },
  {
    "ts": null,
    "headline": "Zoetis: This Beautifully Boring, Slow-Growing Compounder Is A Buy",
    "summary": "Zoetis, a leading animal health company, has shown impressive growth with a 17.55% CAGR since its IPO. Read why I rate ZTS stock a Buy now.",
    "url": "https://finnhub.io/api/news?id=b02e8a4d54768a2158d8e4696333123f7e491d50d8bf941ea6c0fab1b2b86d91",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731903372,
      "headline": "Zoetis: This Beautifully Boring, Slow-Growing Compounder Is A Buy",
      "id": 131438224,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/601800909/image_601800909.jpg?io=getty-c-w1536",
      "related": "ZTS",
      "source": "SeekingAlpha",
      "summary": "Zoetis, a leading animal health company, has shown impressive growth with a 17.55% CAGR since its IPO. Read why I rate ZTS stock a Buy now.",
      "url": "https://finnhub.io/api/news?id=b02e8a4d54768a2158d8e4696333123f7e491d50d8bf941ea6c0fab1b2b86d91"
    }
  }
]